Search research articles
Contact Us
Filters
Showing results (41-50 of 43) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 43 results.
Nature Medicine
|
July 7, 2014
A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice
Da Young Oh, Evelyn Walenta, Taro E Akiyama, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 23, 2019
<i>N</i>-acetylaspartate availability is essential for juvenile survival on fat-free diet and determines metabolic health
Dina C Hofer, Gabriel Zirkovits, Helmut J Pelzmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2023
Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial
I Ray-Coquard, A Leary, S Pignata, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 43) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 43 results.
Nature Medicine
|
July 7, 2014
A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice
Da Young Oh, Evelyn Walenta, Taro E Akiyama, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 23, 2019
<i>N</i>-acetylaspartate availability is essential for juvenile survival on fat-free diet and determines metabolic health
Dina C Hofer, Gabriel Zirkovits, Helmut J Pelzmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2023
Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial
I Ray-Coquard, A Leary, S Pignata, et al.
Page
of 5